News

Thomas Knechtel appointed to the Board of Directors

Helmbrechts – On 5/1/2015 Thomas Knechtel was appointed to the Board of Directors of RAUMEDIC AG. The business administration and engineering graduate joined the REHAU group in 2006 and changed to RAUMEDIC in 2009. Since then he had worked successfully in various management and committee positions. He has many years of experience in both national and international management of customer projects. Since 2010 he had been responsible for marketing and sales activities within the Business Unit Assembly/Catheters. By joining the senior management, he is taking over the overall strategic and functional management of this area of business.

"With Thomas Knechtel we have gained an excellent board member. He has already demonstrated his strategic expertise in his time as head of marketing and sales in this important area of business," says Martin Bayer, CEO of RAUMEDIC AG, with pleasure.

Knechtel is following in the footsteps of Robert Reichenberger, who retired on April 30. Reichenberger worked for RAUMEDIC and, before its spin-off, for REHAU AG+Co. for over 35 years. An engineer through and through, he always derived great satisfaction from seeing how new and highly innovative medical devices found their way to patients and helped them getting better. Martin Bayer thanked Robert Reichenberger for his decades of commitment to the plastics company. "With his knowledge and his tireless effort he contributed in great measure to the success of the company."

The Assembly/Catheters division is one of three fields of business of RAUMEDIC AG. Here, the company's own tubing and molded parts develop into catheters, as well as customized assemblies and complete systems. Therefore the medical technology company offers its customers the option of obtaining everything from a single source. Besides the OEM products, the employees of this business unit develop and produce high-precision pressure measurement systems with microchip technology for the indication areas of neuromonitoring, urology and traumatology. These products are sold to clinics and doctor's offices throughout the world.

Since May 1 of this year, the RAUMEDIC AG Board of Directors has consisted of Martin Bayer (CEO), Michael Stellwag (CFO), Dr. Ralf Ziembinski (Director Business Unit Extrusion/Tubing), Dr. Thomas Jakob (Director Business Unit Molding/Pharma Solutions ), Thomas Knechtel (Director Business Unit Assembly/Catheters), and Martin Schenkel (Director of Operations).

Thomas Knechtel, Director Business Unit Assembly/Catheters and member of the Board of Directors of RAUMEDIC AG